Dermabond Treatment for Gastric Variceal Bleeding
- Conditions
- Gastric Varices
- Interventions
- Procedure: DermaBond treatment of Gastric Varices
- Registration Number
- NCT02037659
- Lead Sponsor
- Indiana University
- Brief Summary
The purpose of having a database is to collect data related to endoscopic ultrasound procedures performed by Indiana University EUS physicians; specifically, for the treatment of gastric variceal bleeding This data will be used for research purposes only to determine the clinical impact of endoscopic ultrasound treatment of gastric variceal bleeding. The physicians will also be able to better understand the patient's condition and disease process that may lead to improved standard of care and improved patient management.
- Detailed Description
Clinical outcomes research is one of the strengths of the EUS group. As a group, the physicians need a tracking system for specific treatment modalities, and data to determine the impact of endoscopic ultrasound for patients with gastric variceal bleeding. Gastric variceal bleeding is a severe complication of portal hypertension with significant morbidity and mortality with limited therapeutic options. Currently, there is no database in existence for endoscopic ultrasound clinical research for specific procedures. Also, there is limited data regarding the outcome of endoscopic sclerotherapy with cyanoacrylate in the United States.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 98
Anyone receiving treatment with DermaBond for treatment gastric varices.
No evidence of gastric varices.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Gastric Varices treatment DermaBond treatment of Gastric Varices DermaBond (glue) treatment of Gastric Varices.
- Primary Outcome Measures
Name Time Method To determine the clinical impact of endoscopic ultrasound treatment of gastric variceal bleeding. 36 months Patients with gastric variceal bleeding will be treated with DermaBond injection via EUS (endoscopic ultrasound). A follow-up EUS will observe the treated varices and determine if retreatment with DermaBond is necessary, or if observation alone is required.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Indiana University Hospital
🇺🇸Indianapolis, Indiana, United States